Patent Assignment
Reel/Frame 029043/0257
Assignment of Assignor's Interest
Recorded: 2012-09-28
Pages: 4
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Use of ERBB3 Inhibitors in the Treatment of Triple Negative and Basal-Like Breast Cancers
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Dec 28, 2015
From: MERRIMACK PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 037394/0285 →
Release of Security Interest
Apr 14, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 042254/0349 →
Assignment of Assignor's Interest
Aug 12, 2019
From: MERRIMACK PHARMACEUTICALS, INC.
To: 14NER ONCOLOGY, INC.
Reel/Frame 050024/0722 →